India's healthcare marketing landscape is multi-tier: metro CPCs differ from tier-2 by 2-3×; specialty CPLs differ by 4-6×; AEO visibility differs by language and search behaviour. ICG runs India-wide engagements with city-level calibration baked in.
The Indian hair transplant market — the national scale and structure
Hair transplant is the fastest-growing aesthetic procedure category in India. Market value approximately ₹1,800 crore (FY25, estimated) growing at approximately 22% CAGR — driven by rising male-pattern-baldness awareness, technique evolution (FUE / DHI / robotic systems), price compression as competition intensifies, and a significant Gulf-NRI medical tourism inflow.
The FUE-FUT-DHI technique split
Three primary hair-transplant techniques operate in the Indian market with materially different patient demographics, pricing, and marketing dynamics:
Follicular Unit Extraction (FUE) — the dominant technique today, accounting for approximately 70% of Indian hair-transplant procedures. Lower scarring, faster recovery, suited to lower-graft-count cases (typically 1,500-3,500 grafts). Pricing range ₹30-90 per graft, total procedure ₹50K-2L. Follicular Unit Transplantation (FUT) — older strip-extraction technique, declining share, suited to high-graft-count cases (4,000+ grafts) where FUE becomes time-prohibitive. Pricing range ₹25-60 per graft. Direct Hair Implantation (DHI) — premium robotic-assisted variant, faster grafting, suited to specific scalp conditions. Pricing range ₹60-120 per graft. National hair-transplant marketing must address technique-specific patient queries — patients research extensively before booking.
Delhi as India's hair transplant capital
Delhi NCR hosts India's largest concentration of hair-transplant clinics — DermaClinix, Eugenix, AK Clinics, Skin Decor as the dominant Delhi players. Delhi captures approximately 35% of India's hair-transplant procedure volume. Mumbai, Bangalore, and Hyderabad are secondary markets. The Delhi market dynamic — multi-chain competition for the male 28-50 demographic — pushes Delhi hair-transplant CPQL to approximately ₹1,500 ICG median (₹2,400 market). Other metros run materially lower.
National hair transplant CPQL benchmark
The Q2 2026 ICG benchmark across 18 hair-transplant clients shows national median CPQL of ₹1,350 (ICG) vs ₹2,100 market median. The hair-transplant CPQL is the highest in the dermatology-adjacent category — driven by the longer 45-90 day consideration cycle, the higher per-procedure cost, and the male-patient research intensity (8-15 sources consulted before booking, per ICG patient research data).
NMC + Schedule J considerations
Schedule J of the Drugs and Cosmetics Rules prohibits drug-advertising for "baldness" — meaning drug-claim advertising for hair-loss treatments to the public is prohibited. Surgical hair-transplant marketing operates outside Schedule J (it is a surgical service, not a drug claim). NMC restrictions on before-and-after imagery of identifiable patients apply — ICG-managed hair-transplant marketing operates within NMC alternatives: consent-verified video journey testimonials, anonymised statistical outcomes, procedure-demonstration content.
